Crossref journal-article
Springer Science and Business Media LLC
Molecular Psychiatry (297)
Bibliography

Xu, R., Hranilovic, D., Fetsko, L. A., Bucan, M., & Wang, Y. (2002). Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Molecular Psychiatry, 7(10), 1075–1082.

Authors 5
  1. R Xu (first)
  2. D Hranilovic (additional)
  3. L A Fetsko (additional)
  4. M Bucan (additional)
  5. Y Wang (additional)
References 29 Referenced 58
  1. Carlsson A . Thirty years of dopamine research Adv Neurol 1993 60: 1–10 / Adv Neurol by A Carlsson (1993)
  2. Nordstrom A-L, Farde L, Wiesel F-A, Forslund K, Pauli S, Halldin C et al. Central D2- dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients Biol Psychiatry 1993 33: 227–235 (10.1016/0006-3223(93)90288-O) / Biol Psychiatry by A-L Nordstrom (1993)
  3. Farde L, Nordstrom A-L, Wiesel F-A, Pauli S, Halldin C, Sedvall G . PET-analysis of central D-2 and D2-dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine — relation to extrapyramidal side effects Arch Gen Psychiatry 1992 49: 538–544 (10.1001/archpsyc.1992.01820070032005) / Arch Gen Psychiatry by L Farde (1992)
  4. Langtry HD, Clissold SP . Pergolide — a review of its pharmacological properties and therapeutic potential in Parkinson's disease Drugs 1990 39: 491–506 (10.2165/00003495-199039030-00009) / Drugs by HD Langtry (1990)
  5. Grillon C, Ameli R, Charney DS, Krystal J, Braff D . Startle gating deficits occur across prepulse intensities in schizophrenic patients Biol Psychiatry 1992 32: 939–943 (10.1016/0006-3223(92)90183-Z) / Biol Psychiatry by C Grillon (1992)
  6. Swerdlow NR, Braff DL, Taaid N, Geyer MA . Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients Arch Gen Psychiatry 1994 51: 139–154 (10.1001/archpsyc.1994.03950020063007) / Arch Gen Psychiatry by NR Swerdlow (1994)
  7. Peng RY, Mansbach RS, Braff DL, Geyer MA . A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Indications for dopaminergic abnormalities in schizophrenia Neuropsychopharmacology 1990 3: 211–218 / Neuropsychopharmacology by RY Peng (1990)
  8. Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E . Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man J Psychopharmacol 1998 12: 239–245 (10.1177/026988119801200302) / J Psychopharmacol by KA Abduljawad (1998)
  9. Ralph RJ, Varty GB, Kely MA, Wang YM, Caron MG, Rubinstein M et al. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice J Neurosci 1999 19: 4627–4633 (10.1523/JNEUROSCI.19-11-04627.1999) / J Neurosci by RJ Ralph (1999)
  10. Ralph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA . Prepulse inhibition deficits and perserverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists J Neurosci 2001 21: 305–313 (10.1523/JNEUROSCI.21-01-00305.2001) / J Neurosci by RJ Ralph (2001)
  11. Wang Y, Xu R, Toshikuni S, Tonegawa S, Kung M-P, Sankoorikal E-B . Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions J Neurosci 2000 20: 8305–8314 (10.1523/JNEUROSCI.20-22-08305.2000) / J Neurosci by Y Wang (2000)
  12. Neve KA, Neve RL, Fidel S, Janowsky A, Higgins GA . Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation Proc Natl Acad Sci USA 1991 88: 2802–2806 (10.1073/pnas.88.7.2802) / Proc Natl Acad Sci USA by KA Neve (1991)
  13. Vukhac K-L, Sankoorikal E-B, Wang Y . Dopamine D2L receptor- and age-related reduction in offensive aggression NeuroReport 2001 12: 1035–1038 (10.1097/00001756-200104170-00034) / NeuroReport by K-L Vukhac (2001)
  14. Nolan PM, Kapfhamer D, Bucan M . Random mutagenesis screen for dominant behavioral mutations in mice Methods: A Companion to Meth Enzymol 1997 13: 379–395 (10.1006/meth.1997.0545) / Methods: A Companion to Meth Enzymol by PM Nolan (1997)
  15. Tarantino LM, Gould TJ, Druhan JP, Bucan M . Behavior and mutagenesis screens: the importance of baseline analysis of inbred strains Mammalian Genome 2000 11: 555–564 (10.1007/s003350010107) / Mammalian Genome by LM Tarantino (2000)
  16. Seeman P, Tallerico T . Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors Mol Psychiatry 1998 3: 123–134 (10.1038/sj.mp.4000336) / Mol Psychiatry by P Seeman (1998)
  17. Castro SW, Strange PG . Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor J Neurochem 1993 60: 372–375 (10.1111/j.1471-4159.1993.tb05863.x) / J Neurochem by SW Castro (1993)
  18. Malmberg A, Jackson DM, Eriksson A, Mohell N . Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors Mol Pharmacol 1993 43: 749–754 / Mol Pharmacol by A Malmberg (1993)
  19. Usiello A, Baik J-H, Rouge-Pont F, Picetti R, Dierich A, LeMeur M et al. Distinct functions of the two isoforms of dopamine D2 receptors Nature 2000 408: 199–203 (10.1038/35041572) / Nature by A Usiello (2000)
  20. Hoffman DC, Donovan H . Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability Psychopharmacology 1995 120: 128–133 (10.1007/BF02246184) / Psychopharmacology by DC Hoffman (1995)
  21. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G et al. Locomotor activity in D2 dopamine receptor deficient mice is determined by gene dosage, genetic background, and developmental adaptations J Neurosci 1998 18: 3470–3479 (10.1523/JNEUROSCI.18-09-03470.1998) / J Neurosci by MA Kelly (1998)
  22. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S . Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses Cell 1994 79: 729–742 (10.1016/0092-8674(94)90557-6) / Cell by M Xu (1994)
  23. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine Nature 1991 350: 610–614 (10.1038/350610a0) / Nature by HH Van Tol (1991)
  24. Bristow LJ, Kramer MS, Kulagowski J, Patel S, Ragan CI, Seabrook GR . Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist Trends Pharmacol Sci 1997 18: 186–188 (10.1016/S0165-6147(97)90618-0) / Trends Pharmacol Sci by LJ Bristow (1997)
  25. Davis M, Svensson TH, Aghajanian GK . Effects of d- and l-amphetamine on habituation and sensitization of the acoustic startle response in rats Psychopharmacology 1975 43: 1–11 (10.1007/BF00437607) / Psychopharmacology by M Davis (1975)
  26. Vandergriff J, Kallman MJ, Rasmussen K . Moxonidine, a selective imidazoline-1 receptor agonist, suppresses the effects of ethanol withdrawal on the acoustic startle response in rats Biol Psychiatry 2000 15: 874–879 (10.1016/S0006-3223(00)00229-8) / Biol Psychiatry by J Vandergriff (2000)
  27. Kokkinidis L . Sensitization to amphetamine and tolerance to cocaine and phencyclidine stimulation in mice Pharmacol Biochem Behav 1986 25: 1175–1180 (10.1016/0091-3057(86)90107-3) / Pharmacol Biochem Behav by L Kokkinidis (1986)
  28. Wood GK, Tomasiewicz H, Rutishauser U, Magnuson T, Quirion R, Rochford J, Srivastava LK . NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle NeuroReport 1998 9: 461–466 (10.1097/00001756-199802160-00019) / NeuroReport by GK Wood (1998)
  29. Swerdlow NR, Braff DL, Geyer MA . Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon Behav Pharmacol 2000 11: 185–204 (10.1097/00008877-200006000-00002) / Behav Pharmacol by NR Swerdlow (2000)
Dates
Type When
Created 22 years, 8 months ago (Dec. 13, 2002, 6:57 a.m.)
Deposited 3 years, 5 months ago (March 31, 2022, 11:31 p.m.)
Indexed 1 week, 6 days ago (Aug. 19, 2025, 6:15 a.m.)
Issued 22 years, 9 months ago (Dec. 1, 2002)
Published 22 years, 9 months ago (Dec. 1, 2002)
Published Online 22 years, 8 months ago (Dec. 12, 2002)
Published Print 22 years, 9 months ago (Dec. 1, 2002)
Funders 0

None

@article{Xu_2002, title={Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice}, volume={7}, ISSN={1476-5578}, url={http://dx.doi.org/10.1038/sj.mp.4001145}, DOI={10.1038/sj.mp.4001145}, number={10}, journal={Molecular Psychiatry}, publisher={Springer Science and Business Media LLC}, author={Xu, R and Hranilovic, D and Fetsko, L A and Bucan, M and Wang, Y}, year={2002}, month=dec, pages={1075–1082} }